Clinical Evaluation of the IONA Test for Non-invasive Pre Natal Screening in Twin Pregnancies
NCT03200041 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000
Last updated 2020-06-11
Summary
The purpose of this study is to evaluate the performance of the IONA® test which is a non-invasive prenatal test (NIPT) for Down's syndrome and other chromosomal abnormalities in twin pregnancies, from a maternal blood sample.
Conditions
- Down Syndrome
- Patau Syndrome
- Edward's Syndrome
Interventions
- PROCEDURE
-
Blood sample
20 ml blood sample taken from vein in arm
Sponsors & Collaborators
-
Premaitha Health
lead INDUSTRY
Principal Investigators
-
Asma Khalil, MBBS · National Health Service, United Kingdom
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- SCREENING
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 16 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-02-29
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Non Invasive Prenatal Testing of Down Syndrome
NCT02127515 ·Status: COMPLETED ·Phase: NA
-
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
NCT01429389 ·Status: RECRUITING
-
Ensuring Patients' Informed Access to Noninvasive Prenatal Testing
NCT03420274 ·Status: COMPLETED ·Phase: NA
-
T21,18 and 13 Screening by Cell Free Fetal DNA in Low Risk Patients
NCT02424474 ·Status: COMPLETED ·Phase: NA
-
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
NCT02109770 ·Status: COMPLETED
-
Comparison of Aneuploidy Risk Evaluations
NCT01663350 ·Status: COMPLETED
-
Prenatal Test for Fetal Aneuploidy Detection
NCT01256606 ·Status: COMPLETED
-
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
NCT01555346 ·Status: COMPLETED
-
Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
NCT00770458 ·Status: COMPLETED
-
Non-Invasive Screening for Fetal Aneuploidy
NCT02317965 ·Status: UNKNOWN
-
Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies
NCT01052688 ·Status: COMPLETED
-
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
NCT04595201 ·Status: RECRUITING
-
Down Syndrome - Comparison of Screening Methods in the 1st and 2nd Trimesters
NCT00006445 ·Status: UNKNOWN ·Phase: NA
-
VAlidation of a Lower Cost aneUploidy scrEen
NCT03087357 ·Status: COMPLETED
-
Non-Invasive Screening for Fetal Aneuploidy
NCT00847990 ·Status: COMPLETED
-
A New Prenatal Blood Test for Down Syndrome
NCT00877292 ·Status: COMPLETED
-
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
NCT00971334 ·Status: COMPLETED
-
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
NCT01597063 ·Status: COMPLETED
-
Non-Invasive Determination of Fetal Chromosome Abnormalities
NCT00891852 ·Status: UNKNOWN
-
Clinical Utility of the Addition of a SNP-based NIPT Zygosity Determination in Twin Pregnancy Management.
NCT05312814 ·Status: COMPLETED
-
National Prevalence and Impact of Noninvasive Prenatal Testing
NCT02284399 ·Status: COMPLETED
-
Obstetric and Neonatal Outcomes of Twin Pregnancy
NCT04588597 ·Status: UNKNOWN
-
A Study Collecting Blood Samples From Pregnant Women to Aid in the Development of a Noninvasive Prenatal Test
NCT03620110 ·Status: COMPLETED
-
Down Syndrome Screening Based on Dried Blood Spots and Cell-free Fetal DNA
NCT01837979 ·Status: UNKNOWN
-
Technical Feasibility of the cfDNA Test for Non-invasive Cytogenetic Analysis of Early Miscarriages Versus the Gold Standard Microarray
NCT05900076 ·Status: COMPLETED